0% Complete
صفحه اصلی
/
4th international edition and 13th Iranian Conference on Bioinformatics
New inhibitors of the Toxoplasmosis by in-silico drug repurposing
نویسندگان :
Milad Jaberi
1
Masoud Aliyar
2
Mosleh Kadkhodamohammadi
3
Parva Karimimousivandi
4
1- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2- Faculty of Science, Golestan university, Shahid Beheshti Street, Gorgan, Golestan province, Iran
3- 2. Faculty of Medicine, Central Building, Tabriz University of Medical Sciences, University Street, Tabriz, Iran
4- 3. Friedrich Schiller University Jena, faculty of sciences, Fürstengraben 1, 07743 Jena, Germany
کلمات کلیدی :
Toxoplasma Gondii،Drug repurposing،Docking،Molecular Dynamics
چکیده :
Introduction: The common treatment for toxoplasmosis was pyrimethamine. It has been noticed in recent years that this parasite becomes resistant to this treatment and it thus needs immediate alternative therapies. Materials and Methods: In this study, using drug re-purposing and in silico methods we tried to make selective treatment by inhibiting the Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii which does not exist in mammalians. We screened the FDA approved drugs by molecular docking and, after ranking them by their binding energies and inspecting the top scoring ones, we selected Cefpiramide, Ceftriaxone and Cefotiam as the hit compounds. Afterwards, we used molecular dynamic simulations to evaluate the hit compounds in a much more realistic environment. Results: Through analyzing the results, we have found that all of the hit compounds are effective and can be strongly bound to the active site of the protein. They may therefore be potential candidates for the inhibition of Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii. Conclusion: Given that the predicted compounds are FDA approved drugs, their toxicity profiles are established and their potentially predicted use can be evaluated in clinical trials.
لیست مقالات
لیست مقالات بایگانی شده
Reduced PINK1 Expression in Bladder Cancer: Insights into Autophagy Dysregulation and Therapeutic Potential
Shayan Jahangirzadeh - Mehdi Asghari Vostakolaei - Asadollah Asadi - Masoumeh Valipour
Molecular Docking Study of Pyrazole Interaction with Bovine Serum Albumin (BSA): Insights from Drug-Protein Binding
Parisa Zallou - Yaghub Pazhang - Ebrahim Nemati-Kande
Bioinformatic analysis of the role of S100A9 inhibition on reducing the brain metastasis in EGFR-mutant lung cancer
Homa Mollaei
A dynamic co-expression approach reveals Gins2 as a potential upstream modulator of HNSCC metastasis
Nasibeh Khayer - Samira Shabani - Maryam Jalessi - Mohammad Taghi Joghataei - Frouzandeh Mahjoubi
Applying immunoinformatics methods for Multiepitope Vaccine Design against HIV virus Based on the INT, RT, PRO genes
Fatemeh Hassanzadeh - Zahra Hassanzadeh - Ava Hashempour
Curcumin’s Journey Through Cellulose: Binding Dynamics Across Cellulose-derived Bio-Nanofibers
Ayla Esmaeilzadeh - Maryam Azimzadeh Irani - Mehdi Jahanfar - Naser Farrokhi
Comprehensive Analysis of EEG Signals for Machine Learning-Based Depression Detection
Mikaeil Tabarraei - Sepideh Jabbari
Computational study on the inhibitory potential of fungal metabolites against HIV-1 RT
Zohreh Sahhaf Razavi - Ali Ramazani - Armin Zarei
Identification of potential RNA interference targets in bladder cancer through bioinformatics approaches
Sana Sajjadi - Mohammad ali Takhshid
Diagnosis of Diabetic Retinopathy with Fuzzy Technique and Deep Learning
Samaneh Noroozi - Sajad Haghzad Klidbary
بیشتر
ثمین همایش، سامانه مدیریت کنفرانس ها و جشنواره ها - نگارش 42.7.0